PyInvesting

Market research

CNC Centene Corp

NYSE USD Healthcare

Latest close

Loading market data…

Test a moving-average rule with historical data.

Market cap
32B
P/E ratio
Not available
Analyst target
71.6667
Dividend yield
Not available
Beta
1.1

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 4 months ago

Centene Corporation is currently in a long term uptrend where the price is trading 11.9% above its 200 day moving average.

From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.3.

Centene Corporation's total revenue rose by 50.0% to $28B since the same quarter in the previous year.

Its net income has dropped by 105.7% to $-12M since the same quarter in the previous year.

Finally, its free cash flow grew by 426.1% to $3B since the same quarter in the previous year.

Based on the above factors, Centene Corporation gets an overall score of 4/5.